Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Other financing activities (2022 - 2023)

Historic Other financing activities for Praxis Precision Medicines (PRAX) over the last 2 years, with Q3 2023 value amounting to -$4.5 million.

  • Praxis Precision Medicines' Other financing activities fell 421376.15% to -$4.5 million in Q3 2023 from the same period last year, while for Jun 2023 it was $4.6 million, marking a year-over-year change of. This contributed to the annual value of $262000.0 for FY2022, which is 5443.48% down from last year.
  • Per Praxis Precision Medicines' latest filing, its Other financing activities stood at -$4.5 million for Q3 2023, which was down 421376.15% from $4.5 million recorded in Q2 2023.
  • In the past 5 years, Praxis Precision Medicines' Other financing activities registered a high of $4.5 million during Q2 2023, and its lowest value of -$4.5 million during Q3 2023.